KaloBios Seeks End To Investor Suit To Clear Ch. 11 Plan
Drug developer KaloBios Pharmaceuticals told a Delaware bankruptcy judge Tuesday that the company is ready to move toward confirming its Chapter 11 reorganization plan and resolving an adversary proceeding brought by...To view the full article, register now.
Already a subscriber? Click here to view full article